Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis

Systemic juvenile idiopathic arthritis (SJIA) is a chronic inflammatory disease of childhood with elevated serum IL-6 levels. As an inhibitor of IL-6R, tocilizumab (TCZ) has been approved to treat SJIA patients. TCZ-induced hypofibrinogenemia has been only reported in adult cases and limited small c...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Tingyan, Ling, Jiayun, Yang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239447/
https://www.ncbi.nlm.nih.gov/pubmed/37270663
http://dx.doi.org/10.1038/s41598-023-36246-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239447/
https://www.ncbi.nlm.nih.gov/pubmed/37270663
http://dx.doi.org/10.1038/s41598-023-36246-6

Ejemplares similares